These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 23646910)

  • 1. Very-high-dose methadone with minimal toxicity and inadequate pain control in a hospice patient with cancer.
    Latuga NM; Wahler RG
    J Pain Palliat Care Pharmacother; 2013 Jun; 27(2):143-9. PubMed ID: 23646910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent subcutaneous methadone administration in the management of cancer pain.
    Centeno C; Vara F
    J Pain Palliat Care Pharmacother; 2005; 19(2):7-12. PubMed ID: 16061456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transitioning a cancer patient from high-dose intravenous hydromorphone therapy to intravenous methadone.
    LeBaron V; Brody J; Lee EM; Hardin C; Snyder L
    J Pain Palliat Care Pharmacother; 2011; 25(4):356-61. PubMed ID: 22126165
    [No Abstract]   [Full Text] [Related]  

  • 4. Switching from methadone to tapentadol for cancer pain.
    Mercadante S; Ferrera P; Adile C
    J Pain Symptom Manage; 2012 Sep; 44(3):e3-5. PubMed ID: 22819437
    [No Abstract]   [Full Text] [Related]  

  • 5. Myoclonus associated with high-dose parenteral methadone.
    Ito S; Liao S
    J Palliat Med; 2008 Jul; 11(6):838-41. PubMed ID: 18715174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methadone for cancer pain: what have we learned from clinical studies?
    Soares LG
    Am J Hosp Palliat Care; 2005; 22(3):223-7. PubMed ID: 15909785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid switching between transdermal fentanyl and methadone in cancer patients.
    Mercadante S; Ferrera P; Villari P; Casuccio A
    J Clin Oncol; 2005 Aug; 23(22):5229-34. PubMed ID: 16051965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rotation to methadone after opioid dose escalation: How should individualization of dosing occur?
    Zimmermann C; Seccareccia D; Booth CM; Cottrell W
    J Pain Palliat Care Pharmacother; 2005; 19(2):25-31. PubMed ID: 16061458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose ratios between high dose oral morphine or equivalents and oral methadone.
    Chatham MS; Dodds Ashley ES; Svengsouk JS; Juba KM
    J Palliat Med; 2013 Aug; 16(8):947-50. PubMed ID: 23662952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study.
    Bruera E; Palmer JL; Bosnjak S; Rico MA; Moyano J; Sweeney C; Strasser F; Willey J; Bertolino M; Mathias C; Spruyt O; Fisch MJ
    J Clin Oncol; 2004 Jan; 22(1):185-92. PubMed ID: 14701781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methadone for cancer pain: a case report.
    Nixon AJ
    Am J Hosp Palliat Care; 2005; 22(5):337. PubMed ID: 16225353
    [No Abstract]   [Full Text] [Related]  

  • 12. Getting comfortable with methadone.
    J Support Oncol; 2003; 1(1):52. PubMed ID: 15352643
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: subcutaneous methadone-an issue revisited.
    Vielvoye-Kerkmeer AP; van Mansom I
    J Pain Symptom Manage; 2008 Jun; 35(6):572. PubMed ID: 18411020
    [No Abstract]   [Full Text] [Related]  

  • 14. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
    Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
    Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methadone:effective analgesia, confusion, and risk.
    Lipman AG
    J Pain Palliat Care Pharmacother; 2005; 19(2):3-5. PubMed ID: 16061455
    [No Abstract]   [Full Text] [Related]  

  • 16. Methadone.
    Chhabra S; Bull J
    Am J Hosp Palliat Care; 2008; 25(2):146-50. PubMed ID: 18445864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose ratio between morphine and methadone in patients with cancer pain: a retrospective study.
    Lawlor PG; Turner KS; Hanson J; Bruera ED
    Cancer; 1998 Mar; 82(6):1167-73. PubMed ID: 9506365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine-methadone opioid rotation in cancer patients: analysis of dose ratio predicting factors.
    Benítez-Rosario MA; Salinas-Martín A; Aguirre-Jaime A; Pérez-Méndez L; Feria M
    J Pain Symptom Manage; 2009 Jun; 37(6):1061-8. PubMed ID: 19171458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methadone in end-of-life pain management.
    Chau DL; Mason MN
    J Opioid Manag; 2005; 1(5):244-8. PubMed ID: 17319557
    [No Abstract]   [Full Text] [Related]  

  • 20. [Methadone in the treatment of chronic non-malignant pain].
    Bendiksen A; McGehee E; Handberg G
    Ugeskr Laeger; 2007 Apr; 169(17):1568-72. PubMed ID: 17484827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.